Document is current
Any future updates will be listed below
-
Authors
Zhang, Luyu
James, Sydney H.
Standridge, Jennifer
Condray, Ruth
Allen, Daniel N.
Strauss, Gregory P.
- License Information
-
More Information
Article History
Received: 17 June 2024
Accepted: 28 November 2024
First Online: 11 December 2024
Declarations
:
: Dr. Gregory Strauss is one of the original developers of the Brief Negative Symptom Scale (BNSS) and receives royalties and consultation fees from Medavante-ProPhase LLC in connection with commercial use of the BNSS and other professional activities; these fees are donated to the Brain and Behavior Research Foundation. Dr. Strauss has received honoraria and travel support from Medavante-ProPhase LLC for training pharmaceutical company raters on the BNSS. Dr. Strauss has consulted for and/or been on the speaker bureau for Minerva Neurosciences, Acadia, Lundbeck, Sunovion, Boehringer Ingelheim, and Otsuka pharmaceutical companies. All other authors have no relevant disclosures to report.
